Clinical trial
Budesonide for Eosinophilic Esophagitis
NCT00271349 · Swiss EE Study Group, Other · Completed
Key facts
| NCT number | NCT00271349 |
|---|---|
| Title | Budesonide for Eosinophilic Esophagitis |
| Official title | Budesonide for Eosinophilic Esophagitis: a Randomized, Placebo-controlled, Double-blind Treatment Study |
| Acronym | BEE |
| Lead sponsor | Swiss EE Study Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Eosinophilic Esophagitis |
| Intervention type | Drug |
| Interventions | Budesonide |
| Enrollment | 28 |
| Start date | Dec 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Dec 30, 2005 |
| Last update posted | May 22, 2015 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: